NAD+ (nicotinamide adenine dinucleotide, oxidized form) is a small dinucleotide cofactor found in every cell. It shuttles electrons as the NAD+/NADH couple through glycolysis, the tricarboxylic acid pathway and oxidative phosphorylation. What separates it from an ordinary catalytic cofactor is that NAD+ is also consumed: sirtuins, PARP enzymes and the ectoenzyme CD38 cleave the glycosidic bond, release nicotinamide, and use the ADP-ribose portion for protein deacylation, DNA-damage signalling or calcium signalling.
Why NAD+ matters in peptide research
Because it is spent rather than merely recycled, intracellular NAD+ concentration is regarded as a rate-limiting variable in metabolic and ageing models. Rodent studies reported from roughly 2013 onward described age-associated declines in tissue NAD+ and shifts in sirtuin-dependent readouts when precursors were supplied; human data are far smaller and mostly biomarker endpoints rather than outcomes. In catalogs NAD+ therefore sits next to its precursor NMN and next to mitochondrial-derived peptides studied on overlapping mitochondrial endpoints.
Handling differs from a peptide: NAD+ is hygroscopic and hydrolyses in water far faster than a lyophilized peptide, so aqueous working solutions in research protocols are normally prepared fresh, kept cold and protected from alkaline pH.
Related terms and material
AMPK · senolytic · in vitro. Reference material: NAD+ and the NAD+ & glutathione collection. Further reading: NAD+ vs NMN.